Suramin: an anticancer drug with unique biological effects (Q40853543)

From Wikidata

Jump to navigation Jump to search

scientific article published on January 1993

edit

Language	Label	Description	Also known as
English	Suramin: an anticancer drug with unique biological effects	scientific article published on January 1993

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8387401

retrieved

24 September 2017

review article

1 reference

stated in

Europe PubMed Central

title

Suramin: an anticancer drug with unique biological effects (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8387401

retrieved

24 September 2017

main subject

suramin

1 reference

based on heuristic

inferred from title

author name string

A K Larsen

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8387401

retrieved

24 September 2017

language of work or name

English

1 reference

based on heuristic

inferred from title

publication date

1 January 1993

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8387401

retrieved

24 September 2017

published in

Cancer Chemotherapy and Pharmacology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8387401

retrieved

24 September 2017

volume

32

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8387401

retrieved

24 September 2017

issue

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8387401

retrieved

24 September 2017

page(s)

96-98

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8387401

retrieved

24 September 2017

cites work

Inhibition of vacuolar H+-ATPases by fusidic acid and suramin

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8387401

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suramin: A potent inhibitor of the reverse transcriptase of RNA tumor viruses

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8387401

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suramin binds to platelet-derived growth factor and inhibits its biological activity

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8387401

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suramin inhibits cell growth and glycolytic activity and triggers differentiation of human colic adenocarcinoma cell clone HT29-D4

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8387401

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intralysosomal accumulation of polyanions. II. Polyanion internalization and its influence on lysosomal pH and membrane fluidity.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8387401

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suramin, an anti-cancer drug, inhibits protein kinase C and induces differentiation in neuroblastoma cell clone NB2A

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8387401

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Platelet-derived growth factor receptors form a high affinity state in membrane preparations. Kinetics and affinity cross-linking studies

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8387401

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suramin inhibition of growth factor receptor binding and mitogenicity in AKR-2B cells

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8387401

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of suramin, an anti-human immunodeficiency virus reverse transcriptase agent, on protein kinase C. Differential activation and inhibition of protein kinase C isozymes

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8387401

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Experimental animal model for mucopolysaccharidosis: suramin-induced glycosaminoglycan and sphingolipid accumulation in the rat.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8387401

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suramin. A potent inhibitor of melanoma heparanase and invasion

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8387401

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suramin inhibits laminin- and thrombospondin-mediated melanoma cell adhesion and migration and binding of these adhesive proteins to sulfatide

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8387401

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suramin: a potent ATPase inhibitor which acts on the inside surface of the sodium pump

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8387401

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential effects of suramin on the coupling of receptors to individual species of pertussis-toxin-sensitive guanine-nucleotide-binding proteins

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8387401

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential inhibition of various deoxyribonucleic and ribonucleic acid polymerases by suramin.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8387401

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suramin: a potent inhibitor of the calcium transport in sarcoplasmic reticulum.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8387401

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suramin: With Special Reference to Onchocerciasis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8387401

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suramin inhibits proliferation of rat glioma cells and alters N-CAM cell surface expression.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8387401

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suramin affects DNA synthesis in HeLa cells by inhibition of DNA polymerases.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8387401

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficient reversion of simian sarcoma virus-transformation and inhibition of growth factor-induced mitogenesis by suramin

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8387401

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition by suramin of mitochondrial ATP synthesis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8387401

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suramin: an anticancer drug with a unique mechanism of action.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8387401

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Circulating glycosaminoglycan anticoagulants associated with suramin treatment

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8387401

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antiproliferative effects of suramin on lymphoid cells

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8387401

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suramin blockade of insulinlike growth factor I-stimulated proliferation of human osteosarcoma cells

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8387401

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of suramin on the activities of degradative enzymes of sphingolipids in rats

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8387401

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suramin therapy in AIDS and related disorders. Report of the US Suramin Working Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8387401

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intralysosomal accumulation of polyanions. I. Fusion of pinocytic and phagocytic vacuoles with secondary lysosomes

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8387401

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effects of antimicrobial agents on ribonucleic acid polymerase

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8387401

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Disruption of cellular energy balance by suramin in intact human prostatic carcinoma cells, a likely antiproliferative mechanism

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8387401

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bovine brain-derived growth factor. Purification and characterization of its interaction with responsive cells

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8387401

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suramin alters phosphoinositide synthesis and inhibits growth factor receptor binding in HT-29 cells

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8387401

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suramin protection of T cells in vitro against infectivity and cytopathic effect of HTLV-III.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8387401

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suramin is an inhibitor of DNA topoisomerase II in vitro and in Chinese hamster fibrosarcoma cells

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8387401

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/BF00685609

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8387401

retrieved

24 September 2017

Dimensions Publication ID

1043060845

0 references

PubMed publication ID

8387401

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8387401

retrieved

24 September 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40853543&oldid=2204038283"